The FDA announced yesterday that it has approved the first treatment for thyroid eye disease: teprotumumab-trbw (Tepezza, Horizon Therapeutics).
Restoring normal thyroid function may reverse cold-induced thermogenesis, say researchers writing in the journal Thyroid.
Adults with subclinical hypothyroidism do not need thyroid hormone therapy in most cases, states a BMJ Rapid Recommendation issued this month.
Thyroid hormones have a wide range of effects of the cardiovascular system. Too much or too little thyroiid hormones can induce or exacerbate existing cardiovascular disorders. In this article, we highlight the treatment recommendations for thyroid-related CVD events.
Healthcare providers are increasingly looking for signs of opioid-induced adrenal insufficiency (OIAI) in their patients, according to a presentation made at the AACE annual meeting held in Los Angeles last week.
Primary care providers, endocrinologists and obstetricians have been challenged with the question of whether to screen all pregnant women for thyroid disease. The debate springs primarily from unknown clinical implications of subclinical thyroid disease during pregnancy. This issue was addressed at ENDO 2019.
Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.
Is thyroid cancer the exception to the rule that alcohol consumption is linked to an increased risk of developing cancer?
Recent findings in thyroid cancer treatment, including laser ablation therapy, lenvatinib, and guidelines for treating pediatric patients, are shown in the following slides.